These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 11364705)

  • 1. Low-dose paclitaxel effective in advanced KS.
    Bartnof HS
    BETA; 1997 Sep; ():51. PubMed ID: 11364705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multicenter trial of low-dose paclitaxel in patients with advanced AIDS-related Kaposi sarcoma.
    Tulpule A; Groopman J; Saville MW; Harrington W; Friedman-Kien A; Espina BM; Garces C; Mantelle L; Mettinger K; Scadden DT; Gill PS
    Cancer; 2002 Jul; 95(1):147-54. PubMed ID: 12115328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of recurrent Kaposi's sarcoma of an AIDS patient with weekly paclitaxel.
    Hsu CH; Chen MY; Cheng AL
    Anticancer Res; 2000; 20(2B):1159-61. PubMed ID: 10810414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paclitaxel is safe and effective in the treatment of advanced AIDS-related Kaposi's sarcoma.
    Gill PS; Tulpule A; Espina BM; Cabriales S; Bresnahan J; Ilaw M; Louie S; Gustafson NF; Brown MA; Orcutt C; Winograd B; Scadden DT
    J Clin Oncol; 1999 Jun; 17(6):1876-83. PubMed ID: 10561228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paclitaxel for AIDS-associated Kaposi's sarcoma.
    Dhillon T; Stebbing J; Bower M
    Expert Rev Anticancer Ther; 2005 Apr; 5(2):215-9. PubMed ID: 15877519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paclitaxel for treating KS.
    Proj Inf Perspect; 1997 Nov; (23):15. PubMed ID: 11365372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of AIDS-related Kaposi's sarcoma: advances in target discovery and treatment.
    Dezube BJ
    Expert Rev Anticancer Ther; 2002 Apr; 2(2):193-200. PubMed ID: 12113241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic treatment of AIDS-related Kaposi sarcoma: current status and perspectives.
    Vanni T; Sprinz E; Machado MW; Santana Rde C; Fonseca BA; Schwartsmann G
    Cancer Treat Rev; 2006 Oct; 32(6):445-55. PubMed ID: 16860939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liposomal KS drugs approved.
    GMHC Treat Issues; 1996 Apr; 10(4):8-9. PubMed ID: 11363710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful treatment with paclitaxel of advanced AIDS-associated Kaposi's sarcoma.
    Kobayashi M; Takaori-Kondo A; Shindo K; Mizutani C; Ishikawa T; Uchiyama T
    Intern Med; 2002 Dec; 41(12):1209-12. PubMed ID: 12521218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. All-trans retinoic acid for the treatment of AIDS-related Kaposi's sarcoma: results of a pilot phase II study.
    Gill PS; Espina BM; Moudgil T; Kidane S; Esplin JA; Tulpule A; Levine AM
    Leukemia; 1994; 8 Suppl 3():S26-32. PubMed ID: 7808021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-cancer agents. A new treatment for Kaposi's sarcoma?
    TreatmentUpdate; 2002; 14(7):6-8. PubMed ID: 12400501
    [No Abstract]   [Full Text] [Related]  

  • 13. Management of AIDS-related Kaposi sarcoma: advances in target discovery and treatment.
    Dezube BJ; Pantanowitz L; Aboulafia DM
    AIDS Read; 2004 May; 14(5):236-8, 243-4, 251-3. PubMed ID: 15199854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost effectiveness of liposomal doxorubicin vs. paclitaxel for the treatment of advanced AIDS-Kaposi's sarcoma.
    Raimundo K; Biskupiak J; Goodman M; Silverstein S; Asche C
    J Med Econ; 2013; 16(5):606-13. PubMed ID: 23425295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paclitaxel in the treatment of human immunodeficiency virus 1-associated Kaposi's sarcoma--drug-drug interactions with protease inhibitors and a nonnucleoside reverse transcriptase inhibitor: a case report study.
    Nannan Panday VR; Hoetelmans RM; van Heeswijk RP; Meenhorst PL; Inghels M; Mulder JW; Beijnen JH
    Cancer Chemother Pharmacol; 1999; 43(6):516-9. PubMed ID: 10321513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FDA approves DaunoXome as first-line therapy for Kaposi's sarcoma. Food and Drug Administration.
    J Int Assoc Physicians AIDS Care; 1996 May; 2(5):50-1. PubMed ID: 11363534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AIDS-related Kaposi's sarcoma: a phase II study of liposomal doxorubicin. The TLC D-99 Study Group.
    Cheung TW; Remick SC; Azarnia N; Proper JA; Barrueco JR; Dezube BJ
    Clin Cancer Res; 1999 Nov; 5(11):3432-7. PubMed ID: 10589755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DaunoXome offers KS treatment alternative.
    AIDS Alert; 1996 Jun; 11(6):67-8. PubMed ID: 11363544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kaposi's sarcoma: DOX-SL approval recommended.
    AIDS Treat News; 1995 Feb; (no 217):8. PubMed ID: 11362308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful treatment with three-weekly paclitaxel of an anthracycline-refractory classical Kaposi's sarcoma.
    Silvestris N; Galetta D; Colucci G
    Anticancer Res; 2009 Feb; 29(2):675-6. PubMed ID: 19331220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.